134 related articles for article (PubMed ID: 16525633)
1. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion.
Ding Y; Wang G; Ling MT; Wong YC; Li X; Na Y; Zhang X; Chua CW; Wang X; Xin D
Int J Oncol; 2006 Apr; 28(4):847-54. PubMed ID: 16525633
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer.
Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X
Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024
[TBL] [Abstract][Full Text] [Related]
3. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
4. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
5. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R
Oncogene; 2009 Apr; 28(17):1881-91. PubMed ID: 19330020
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor-regulated human bladder cancer motility is in part a phosphatidylinositol 3-kinase-mediated process.
Theodorescu D; Laderoute KR; Gulding KM
Cell Growth Differ; 1998 Nov; 9(11):919-28. PubMed ID: 9831244
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells.
Hu H; Zhang XP; Wang YL; Chua CW; Luk SU; Wong YC; Ling MT; Wang XF; Xu KX
Mol Med Rep; 2011; 4(1):9-16. PubMed ID: 21461556
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder.
Wang X; Zhang S; MacLennan GT; Eble JN; Lopez-Beltran A; Yang XJ; Pan CX; Zhou H; Montironi R; Cheng L
Clin Cancer Res; 2007 Feb; 13(3):953-7. PubMed ID: 17289890
[TBL] [Abstract][Full Text] [Related]
9. Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment.
Qu XJ; Yang JL; Russell PJ; Goldstein D
J Urol; 2004 Aug; 172(2):733-8. PubMed ID: 15247772
[TBL] [Abstract][Full Text] [Related]
10. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.
Schindl M; Schoppmann SF; Ströbel T; Heinzl H; Leisser C; Horvat R; Birner P
Clin Cancer Res; 2003 Feb; 9(2):779-85. PubMed ID: 12576450
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
Cardillo MR; Castagna G; Memeo L; De Bernardinis E; Di Silverio F
J Exp Clin Cancer Res; 2000 Jun; 19(2):225-33. PubMed ID: 10965823
[TBL] [Abstract][Full Text] [Related]
12. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.
Ou L; Guo Y; Luo C; Wu X; Zhao Y; Cai X
Cancer Genet Cytogenet; 2010 Jul; 200(2):110-9. PubMed ID: 20620593
[TBL] [Abstract][Full Text] [Related]
13. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
16. Silencing Id-1 with RNA interference inhibits adenoid cystic carcinoma in mice.
Chen Z; Liu S; Sumida T; Sun S; Wei Y; Liu M; Dong Z; Zhang F; Hamakawa H; Wei F
J Surg Res; 2011 Jul; 169(1):57-66. PubMed ID: 20189601
[TBL] [Abstract][Full Text] [Related]
17. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
[TBL] [Abstract][Full Text] [Related]
18. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.
Kawanishi H; Matsui Y; Ito M; Watanabe J; Takahashi T; Nishizawa K; Nishiyama H; Kamoto T; Mikami Y; Tanaka Y; Jung G; Akiyama H; Nobumasa H; Guilford P; Reeve A; Okuno Y; Tsujimoto G; Nakamura E; Ogawa O
Clin Cancer Res; 2008 May; 14(9):2579-87. PubMed ID: 18451219
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
20. LRIG1, a candidate tumour-suppressor gene in human bladder cancer cell line BIU87.
Yang WM; Yan ZJ; Ye ZQ; Guo DS
BJU Int; 2006 Oct; 98(4):898-902. PubMed ID: 16978290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]